Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEP-DOWN HF Trial
NCT07631156Phase 4Recruiting
- Sponsor
- Kyungsub Song
- Start
- Aug 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in heart failure (HF) (2 arms), sponsored by Kyungsub Song. Primary endpoint: Change in Left Ventricular Ejection Fraction at 12 months. Started Aug 2026; status: recruiting.
02
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07631156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07631156.